A dedicated CAR T-cell therapy center in Shanghai, treating international patients with relapsed or refractory blood cancers.
The CAR T-Cell Therapy Center was established to provide safe, effective cell therapy to patients worldwide, with a primary focus on CAR T-cell treatment.
CAR T-cell therapy is a form of treatment in which a patient's own T cells are collected, modified to recognize a target on cancer cells, and returned to the body. China's National Medical Products Administration has approved a number of these therapies for specific blood cancers.
The Center is part of SinoUnited Health, a private healthcare group in Shanghai. Shanghai SinoUnited Hospital, where CAR T-cell therapy is delivered, opened in December 2022.
The hospital, its wards and its facilities are described in more detail on the hospital page.
Shanghai SinoUnited Hospital features in independent reporting on CAR T-cell therapy in Shanghai, collected in the news section.
SinoUnited Health was among the first in Shanghai to receive this designation from the China Non-government Medical Institutions Association.
The place, the clinicians and the city — each described in full on its own page.
Not sure whether CAR T-cell therapy applies to your diagnosis? A remote eligibility assessment is free and reviewed by the hematology team.
Check eligibility →
